NCT02567578

A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

A Multicenter, Randomized, Double-blind, Placebo-controlled Dose-finding Phase 2 Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2 trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia.

Detailed description

Eligible subjects will be randomized into one of 4 groups; YH12852 0.1 mg, 0.25 mg, 0.5 mg, or placebo at the same ratio and will be administered investigational products orally, twice daily for 4 weeks and followed up for 2 weeks.

Conditions

• Functional Dyspepsia

Interventions

Type	Name	Description
DRUG	YH12852 0.1 mg
DRUG	YH12852 0.25 mg
DRUG	YH12852 0.5 mg
DRUG	Placebo

Timeline

• Start date: 2015-10-01
• Primary completion: 2017-03-16
• Completion: 2017-03-16
• First posted: 2015-10-05
• Last updated: 2022-01-13

Locations

1 site across 1 country: South Korea